 3  1 
INTRODUCTION 5 0
Physical inactivity is now recognized as a global pandemic promoting the development of numerous 5 1 chronic diseases including coronary heart diseases, type 2 diabetes, cancer or dementia (Booth et al.,
1 1 1 MATERIAL AND METHODS 1 1 2
All procedures described below were approved by the French Ministry of Higher Education and 1 1 3
Research in accordance with the local committee on Ethics in Research of Rennes (veterinary service 1 1 4 of health and animal protection, authorization 01259.03). 1 1 5
Animal care and protocol. To mimic the effects of physical inactivity in mice, we used the wheel lock 1 1 6 model first developed by Frank Booth's research group (Roberts et al., 2012) . Twenty-two male 1 1 7 C57BL/6 mice were obtained at weaning (3 weeks) and allowed to acclimatize for 1 week. The 1 1 8
animals were housed in temperature controlled room (21 ± 2°C) with a 12-h:12-h light/dark cycle and 1 1 9
received standard rodent chow and water ad libitum. After 1 week, mice were separated into individual 1 2 0 cages all equipped with a voluntary running wheel outfitted with a lap counter (IntelliBio, Nancy, 1 2 1 France). Food intake and covered distance were daily noticed whereas body weight was recorded 1 2 2 every week. The distance daily covered increased the first two weeks and remained unchanged during 1 2 3 the next 4 weeks. At the end of this period, mice were assigned to 3 experimental groups with equal 1 2 4 mean and standard deviation for daily covered distance: voluntary wheel access group (Active, n=7), a 1 2 5
wheel lock group (Inactive, n=7) and wheel lock group treated with myriocin (Inactive-Myr, n=8). 1 2 6
Myriocin was daily injected (0.3 mg/kg, i.p) as previously described (Hojjati et al., 2005 ; Lee et al., 1 2 7 2010). In the same schedule, Active and Inactive groups received saline vehicle. After 10 days of 1 2 8 physical inactivity, mice were sacrificed in an overnight fasting state. Mice were anesthetized with a 1 2 9
ketamine-xylazine-butorphanol cocktail. Adipose tissue, rectus femoris (RF) and right tibialis anterior 1 3 0 (TA) muscles were removed, and then immediately frozen in liquid nitrogen. Left tibialis anterior 1 3 1 muscles were removed, and then submitted to an ex vivo insulin sensitivity test. Immediately following 1 3 2 tissue harvest, mice were euthanized via exsanguination of the heart. Intracardiac blood was collected 1 3 3
into dry tubes and centrifuged (1,500 g, 10 min) for serum sampling. 1 3 4
Glucose tolerance assessment. Oral glucose tolerance test (OGTT) was performed on the morning one 1 3 5 day before sacrifice. Mice were fasted for 6h before the test. Then, glucose was administrated by oral 1 3 6
gavage (1 g/kg body weight). Glucose values were obtained at rest and 15, 30, 45, 60, 90, 120 min 1 3 7 after glucose gavage from tail blood samples. Glucose level was determined using a glucose meter 1 3 8
(Freestyle Papillon Vision). Wheels were locked during the whole time of fasting and OGTT. 1 3 9
Ex vivo muscle insulin sensitivity test. As previously described (Tardif et al., 2011) , left tibialis 1 4 0
anterior muscles were longitudinally divided in two strips (20-25 mg) and each strip was pre- ceramide species separation, the gradient started at 95% of eluent B (mobile phase of water and of 1 7 0 methanol with 1% formic acid and 5 mM ammonium formate), up to 98% in 4 min, then rapidly 1 7 1 decreased to 95% for 0.1 min, and was maintained for 2 min. For sphingomyelin species separation, 1 7 2 the gradient started at 95% of eluent B, up to 99% for 6 min, then rapidly decreased to 95% for 0.1 1 7 3 min, and was maintained for 1.4 min. Multiple reaction-monitoring mode in positive electrospray 1 7 4
ionization was used to quantify each species of ceramides and sphingomyelins. The source heater 1 7 5 temperature hold at 150°C, and the capillary voltage was set at 3.2 kV. The flow rate of desolvation 1 7 6
gas was of 650 l/h at 350°C, and the cone voltage varied from 26-58 V. Argon was used as the 1 7 7
collision gas, and collision energies varied from 12-40 eV. Data analyses were performed by Mass 1 7 8
Lynx software version 4.1 (Waters, Manchester, UK). Sphingolipid quantification was possible with 1 7 9 calibration curves constructed by plotting the peak area ratios of analyses to the respective internal 1 8 0 standard against concentration using a linear regression model. The quantification measurements were 1 8 1 performed using the TargetLinks software (Waters of diluted cDNA. The following primer sequences were used: GLUT4: (F: 1 9 0 GCCTGCCCGAAAGAGTCTAA and R: CATTGATGCCTGAGAGCTGTTG); PPIA (F: 1 9 1 CGTCTCCTTCGAGCTGTTTG and R: CCACCCTGGCACATGAATC); HPRT (F: 1 9 2 AGGCCAGACTTTGTTGGATTT and R: CAGGACTCCTCGTATTTGCAG); RPL19 (F: 1 9 3 CAATGCCAACTCTCGTCAACAG and R: CATCCAGGTCACCTTCTCGG). GLUT4 was 1 9 4 normalized using three reference genes (PPPIA, HPRT, RPL19) according to geNorm analysis 1 9 5 (Vandesompele et al., 2002) . 1 9 6
Western Blotting. Cytosolic protein extraction was performed from rectus femoris muscle in cold lysis 1 9 7 buffer containing 10 mM Tris-HCl, pH 7.4, 0.5 M sucrose, 50 mM NaCl, 5 mM EDTA, 30 mM 1 9 8 Na 4 P 2 O 7 , 1% NP-40, 0.25% sodium deoxycholate, 50 mM NaF, 100 µM sodium orthovanadate and 1 9 9
proteases inhibitors cocktail (Sigma P8340, 5 µl/ml). The samples were homogenized using a Polytron 2 0 0 homogenizer at 4°C. Each sample was then incubated on ice for 30 min followed by 3 x 10 s of 2 0 1 sonication. The homogenates were then centrifugated at 12,000g for 12 min at 4°C. The protein 2 0 2 concentration of the supernatant was determined by a Lowry assay using bovine serum albumin (BSA) 2 0 3 as standard. Samples were then diluted in SDS-PAGE sample buffer [50 mM Tris-HCl, pH 6.8, 2% 2 0 4 SDS, 10% glycerol, 5% β -mercaptoethanol, and 0.1% bromophenol blue], and heated 5 min at 95°C 2 0 5 until analyses. Fifty micrograms of proteins were resolved on 12.5% SDS-PAGE. The proteins were 2 0 6 transferred at 240 mA for 90 min onto a 0.2-µm nitrocellulose membrane. Membranes were blocked 2 0 7
with 5% BSA or nonfat dry milk in TBST (Tris-buffered saline -0.05% Tween-20) for 1 h at room 2 0 8
temperature. Membranes were incubated overnight at 4°C with appropriate primary antibodies: AKT 2 0 9
(1:1000, Cell Signaling), p-AKT Ser473 (1:1000, Cell Signaling), AMPK (1:1000, Cell Signaling), p-2 1 0 AMPK Thr172 (1:1000, Cell Signaling), p65 (1:1000, Cell Signaling), p-p65 Ser536 (1:1000, Cell 2 1 1
Signaling), IRS-1 (1:1000, Cell Signaling), pIRS-1 Ser302 (1:1000, Cell Signaling), STAT3 (1:1000, Cell 2 1 2
Signaling), p-STAT3 Ser727 , IκBα (1:1000, Cell Signaling), GLUT4 (1:1000, Abcam), and α -actin 2 1 3
(1:700, Sigma Aldrich). Thereafter, membranes were washed with TBST and incubated for 1 h at 2 1 4 room temperature with infrared dye-conjugated secondary antibodies (LI-COR, Lincoln, NE, USA). 2 1 5
After washing, blots were captured using the Odyssey Imaging System (LI-COR). All blots were 2 1 6
scanned, densitometric analysis of the bands was conducted using GS-800 Imaging densitometer and 2 1 7
QuantityOne software. Phosphospecific signal was normalized to the total signal to estimate the ratio 2 1 8 of activated markers. p=0.007 and 0.01, respectively, Table 1 ). After 10 days of wheel lock, body weight significantly 2 3 4 increased only in Active mice. No significant difference of body weight was observed between the 3 2 3 5
experimental groups before and after the 10 days of physical inactivity. Visceral fat mass did not differ 2 3 6
between the 3 experimental groups at the end of the protocol (Table 1) . 2 3 7
Muscle triglycerides and ceramides content. We first observed that muscle triglyceride (TG) content 2 3 8
tend to increase in Inactive mice (p=0.09, Fig. 1A) whereas it increase in the Inactive-Myr group 2 3 9 (p=0.027, Fig. 1A ). Contrary to our hypothesis, physical inactivity did not modify total, saturated and 2 4 0 unsaturated ceramides content in muscle (Fig. 1B) . Individual ceramides species ranging from C16:0 2 4 1 to C24:1 remained also unchanged after 10 days of physical inactivity (Fig. 1C and 1D) . Surprisingly, 2 4 2 muscle ceramides content were not affected by 10 days of myriocin treatment (Fig. 1B, 1C and 1D ).
4 3
Whole-body insulin sensitivity and glucose tolerance. The effect physical inactivity and myriocin 2 4 4 treatment on whole-body insulin sensitivity was assessed by measuring the circulating level of glucose 2 4 5 and insulin. Fasting glycemia remained unaffected with physical inactivity and myriocin treatment 2 4 6 ( Fig. 2A ). Serum insulin levels were higher in both Inactive and Inactive-Myr groups compared to 2 4 7
Active group (p=0.025 and 0.015, respectively, Fig. 2B ). Such results were associated with a higher 2 4 8
HOMA-IR index in Inactive compared to Active mice (p=0.045, Fig. 2C ), whereas this index did not 2 4 9
differ between Inactive-Myr and Active mice (p=0.17, Fig. 2C ). Thus, myriocin seems to prevent 2 5 0 physical inactivity-induced whole-body insulin resistance. An OGTT was also performed at the end of 2 5 1 the protocol to observe the effects of physical inactivity and myriocin on glucose tolerance. Here, we 2 5 2 did not observe significant difference in glucose concentrations (at all time points) and area under the 2 5 3 curve (AUC) between Active and Inactive mice ( Fig. 2D and E) . However, we reported that Inactive-2 5 4
Myr mice exhibited an AUC significantly lower compared to both Active (p=0.019, Fig. 2D ) and 2 5 5
Inactive mice (p<0.001, Fig. 2D ). This effect was due to a lower glucose levels both at the beginning 2 5 6 and the end of OGTT (15 min, 30 min, 90 and 120 min, p<0.05, Fig. 2E ). Taken together, our results 2 5 7
indicate that myriocin improves glucose tolerance. 2 5 8
Proximal insulin signaling and GLUT4 content in skeletal muscle. We observed a deleterious effect of 2 5 9
physical inactivity on whole-body insulin sensitivity and a beneficial effect of myriocin on glucose 2 6 0 tolerance. To investigate the mechanism regulating such effects, we first evaluated the integrity of 2 6 1 insulin signaling in skeletal muscle by measuring, ex vivo, basal and insulin-stimulated Akt activation. 2 6 2
We observed that insulin stimulation increased phospho-Akt levels in Active (p=0.019), Inactive 2 6 3 the expression of serine palmitoyltransferase 2 (SPT2), a key enzyme in ceramide biosynthesis 2 9 9
(Erickson et al., 2012). Ceramides have been identified as key bioactive sphingolipids in the 3 0 0 development of muscle insulin resistance, especially the C:16 and C:18 moieties, which are the most 3 0 1 abundant in skeletal muscle (Chung et al., 2017; Perreault et al., 2018) . Based on previous data from 3 0 2 our laboratory and others showing in rodents that C:16 and C:18 ceramides increase in skeletal muscle 3 0 3
after 1 or 2 weeks of immobilization (Kwon et al., 2016; Salaun et al., 2016) , we hypothesized that 10 3 0 4
days of physical inactivity induced by wheel lock will also cause muscle ceramide accumulation. 3 0 5
Herein, we show that muscle ceramides are not responsible of insulin resistance induced by physical 3 0 6
inactivity. Contrary to immobilization, we observed that total and saturated ceramide levels in muscle 3 0 7
remained unchanged after 10 days of physical inactivity. This was also the case for muscle TG which 3 0 8
are increase after immobilization (3, 50), while we reported only a trend with physical inactivity. All 3 0 9
together, these results support that immobilization and physical inactivity are not equivalent models to 3 1 0 study the effect of a reduction of energy expenditure. 3 1 1
In rodents, the wheel lock model is currently the closest model to mimic human physical inactivity 3 1 2
(Roberts et al., 2012). Using this model in mice, we observed that 10 days of physical inactivity are 3 1 3 sufficient to induce hyperinsulinemia and to increase the HOMA-IR, both considered as hallmarks of tolerance. Teich and colleagues recently observed that 7 days of wheel lock were sufficient to affect 3 1 8
glucose tolerance in young Sprague-Dawley male rats (Teich et al., 2017) . In the present study, we did 3 1 9
not report an effect on glucose tolerance after 10 days of wheel lock. Our results are in accordance 3 2 0
with data obtained in humans exposed to a reduction in daily number of steps during 5 or 14 days, 3 2 1
where no change in glucose tolerance was reported (Knudsen et al., 2012; Reynolds et al., 2015) . All 3 2 2 together, these results sustain that the wheel lock model is a realistic experimental set-up to study, in 3 2 3 mice, human physical inactivity and its role in chronic diseases development. 3 2 4
Skeletal muscle being responsible of 80% of whole-body glucose uptake under insulin stimulation 3 2 5
( DeFronzo et al., 1985) , early insulin resistance occurring with physical inactivity is mainly attributed 3 2 6
to alterations in skeletal muscle glucose uptake (Knudsen et al., 2012; Krogh-Madsen et al., 2010) .
Interestingly, using the wheel lock model during only 2 days, Kump and Booth observed a reduction 3 2 8 of insulin-stimulated 2-deoxyglucose uptake in skeletal muscle (Kump and Booth, 2005) . Similar 3 2 9
results were also reported in rats submitted to muscle unloading after 24h (Kawamoto et al., 2016 ; et al., 2004) . However, the mechanisms by which physical inactivity and muscle unloading 3 3 1 rapidly induce muscle insulin resistance remain unclear. Krogh-Madsen and colleagues (2010) have 3 3 2
reported that a reduction of muscle Akt phosphorylation during hyperinsulinemic euglycemic clamp 3 3 3 occurred after 2 weeks of reduction of ambulatory activity, thus supporting the idea that insulin 3 3 4 signaling was early affected by physical inactivity. However, if the clamp is the gold standard to 3 3 5 assess peripheral insulin sensitivity, it appears less appropriate to assess insulin signaling. Indeed, 3 3 6 presence of circulating hormones or cytokines (e.g. leptin, adiponectin, IL-6) and muscle contractility 3 3 7 are all factors affecting muscle insulin signaling during clamp, independently of direct action of 3 3 8
insulin. For these reasons, we decided to explore insulin-stimulated muscle Akt phosphorylation in ex-3 3 9
vivo conditions to determine whether insulin signaling was affected with a short period of physical 3 4 0
inactivity. In this condition, we observed that Akt phosphorylation in inactive mice did not differ from 3 4 1 active animals, suggesting that insulin signaling until Akt remains unaffected after 10 days of physical 3 4 2 inactivity. To support such results, we explored the effects of physical inactivity on inflammatory 3 4 3 pathways recognized to affect insulin signaling. Hassan et al., 2016; Morino et al., 2008) . In the present study, we found that physical inactivity did not 3 4 7
modify the phosphorylation state IRS1 Ser302 . Taken together, these results indicate that, in the context 3 4 8
of physical inactivity, the onset of insulin resistance is not due an inflammatory process affecting the 3 4 9 skeletal muscle. 3 5 0
Our data support that muscle insulin signaling does not appear affected by a short period of physical 3 5 1
inactivity. In accordance with Kump and Booth (2005) , we reported that 10 days of wheel lock caused 3 5 2 a significant reduction of GLUT4 pool in skeletal muscle. These results support the idea that 3 5 3
inactivity-induced muscle insulin resistance would be rather related to a decrease of muscle GLUT4 3 5 4
pool than a defect in insulin signaling. Interestingly, we observed that mRNA coding for GLUT4 was 3 5 5
not affected suggesting that the decrease of GLUT4 pool would be due to an increase of its 3 5 6
degradation. It is well established that chronic insulin stimulation causes a decrease of GLUT4 content 3 5 7
in adipocytes, mainly due to an accelerated GLUT4 degradation in the lysosomes (Liu et al., 2007 ; Ma  3  5  8  et al., 2014, p. 4; Sargeant and Pâquet, 1993) . Similar cellular events could occur in skeletal muscle of 3 5 9
inactive. Such mechanisms need to be explored in further experiments. 3 6 0
To explore the role of ceramides in physical inactivity-induced insulin resistance, we treated inactive 3 6 1 mice with myriocin, an inhibitor of de novo synthesis of ceramides. As previously reported in others 3 6 2 experimental models including Zucker diabetic rats or high fat diet-fed mice (Holland et al., 2007 ;  3  6  3 Ussher et al., 2010), we observed that myriocin treatment improved glucose tolerance in inactive mice. 3 6 4
Interestingly, we also reported that myriocin treatment caused a significant increase of AMPK 3 6 5
phosphorylation. This result is in accordance with the data of Liu and colleagues (2013) demonstrating 3 6 6
that myriocin prolonged yeast lifespan by activating key signaling pathways controlling stress 3 6 7
resistance and energy metabolic homeostasis including AMPK signaling pathway. Thus, the beneficial 3 6 8 effect of myriocin on glucose tolerance could be mediated by AMPK (Jensen et al., 2014) .
Interestingly, we also observed higher insulin-stimulated Akt phosphorylation in myriocin-treated 3 7 0 compared to non-treated inactive mice. Such improvement of muscle insulin signaling could be linked 3 7 1
to AMPK activation since this kinase is recognized to enhance the response of Akt phosphorylation on 3 7 2 serine 473 residue through the modulation of MTORC2 complex activity (Kleinert et al., 2016; 3 7 3 Sarbassov et al., 2005) . We also observed that myriocin prevents the decrease of GLUT4 induced by 3 7 4 physical inactivity. Although AMPK has been proposed to stimulate GLUT4 transcription (Gong et  3  7  5 al. , 2011; McGee et al., 2008) , we observed a decrease of GLUT4 mRNA associated with AMPK 3 7 6
activation in Inactive-My compared to Inactive mice. Consequently, an AMPK-independent 3 7 7
mechanism could be responsible of the effect of myriocin on muscle GLUT4 protein. To sum up, the 3 7 8 effect of myriocin on glucose tolerance seems implicated a coordination of AMPK, Akt and GLUT4 in 3 7 9
a manner that needs to be elucidated. Contrary to our hypothesis, the benefits of myriocin treatment on 3 8 0 glucose tolerance are not associated to modulation in muscle ceramide concentrations. The previous 3 8 1 studies reporting in mice a beneficial effect of myriocin on glucose tolerance and insulin sensitivity 3 8 2
were associated to a prevention of muscle ceramide accumulation induced by high fat diet or 3 8 3 pathological genetic background (Holland et al., 2007; Ussher et al., 2010; Yang et al., 2009) . Herein, 3 8 4
we found that myriocin and physical inactivity act on insulin sensitivity independently from 3 8 5
ceramides, thus highlighting the need to explore other hypothesis. 3 8 6
In summary, our results support that muscle ceramide accumulation and inflammatory pathways do 3 8 7
not play a role in physical inactivity-induced insulin resistance. The insulin resistance observed after a 3 8 8
short period of physical inactivity seems related to a reduction in muscle GLUT4 content rather than to 3 8 9
defects of muscle insulin signaling. Our findings also support that immobilization is not what inactive 3 9 0
people experience, and that biological effects obtained with this kind of models should not associated 3 9 1 with physical inactivity. Finally, our data highlight that myriocin could be a promising molecule to 3 9 2 improve glucose tolerance and muscle insulin sensitivity. 3 9 3 3 9 4 ACKNOWLEDGMENTS 3 9 5
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